logo
Cardiologists Are Begging People With High Cholesterol To Stop Doing This One Thing ASAP

Cardiologists Are Begging People With High Cholesterol To Stop Doing This One Thing ASAP

Yahoo2 days ago
Cardiologists Are Begging People With High Cholesterol To Stop Doing This One Thing ASAP originally appeared on Parade.
Heart disease has been the leading cause of death for U.S. adults for a century, according to American Heart Association data. There are many reasons why someone may die from cardiovascular disease, and we can't control all of them. Yet, understanding risk factors and how to control what we can is critical, like managing high cholesterol if you have it.Medication is one way. However, Dr. Patrick Kee, MD, Ph.D., a cardiologist with Vital Heart & Vein in Houston, explains that lifestyle tweaks like diet are crucial, whether you benefit from medication for cholesterol or not. The good news?"Even minor adjustments to your diet can lead to significant clinical benefits if maintained over time, emphasizing the profound impact of self-care in managing high cholesterol and reducing the risk of future heart attacks and strokes," Dr. Kee explains.However, various factors can complicate even making small changes to your diet, and you may unintentionally be consuming some heart-unfriendly foods. Cardiologists share the one habit to break if you have high cholesterol.🩺 💊
The No. 1 Habit Cardiologists Want People With High Cholesterol To Break ASAP
Cardiologists are urging people with high cholesterol to not overlook saturated fat consumption. "We see a significant increase in heart disease risk with high consumption of saturated fats," warns Dr. Bradley Serwer, MD, an interventional cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company.Indeed, research suggests that saturated fat is more likely to affect cholesterol levels than dietary cholesterol, although this can vary from person to person. Not all fats are bad—monounsaturated and polyunsaturated fats that remain liquid at room temperature can have heart-healthy benefits. However, saturated fats, which solidify at room temperature, can pose risks, including higher odds of developing high cholesterol or having complications if you already do.
"Saturated fat, typically found in animal products like red meats and full-fat dairy, influences your liver to produce higher levels of LDL—'bad'—cholesterol in your blood," explains , a cardiologist with Manhattan Cardiology in NYC and labfinder.com contributor. "LDL cholesterol circulates in your blood and can stick to artery walls, forming plaque. Over time, this plaque narrows arteries—a condition called atherosclerosis—and increases the risk of heart attacks and strokes."For this reason, Dr. Suri notes that the American Heart Association recommends limiting your saturated fat consumption to less than 6% of your daily calories."This roughly translates to about 13 grams of saturated fat per day, if someone is consuming 2,000 calories per day," she notes.
Related:
Why It's Hard To Monitor Saturated Fat—Even With High Cholesterol
Limiting saturated fat intake is difficult, even if you've gotten doctor's orders to do so for high cholesterol, concedes Dr. Jeffrey Carstens, MD, MBA, a cardiologist with UnityPoint Health."Controlling saturated fat intake is challenging for many individuals due to its prevalence in a wide array of appealing foods, including many fast-food options, often without obvious labeling," he says. "Frequently unrecognized sources include processed foods, such as ice cream and baked goods."The labels on the front of a food container don't always help you make the best decisions for your cholesterol.
"Food labels can be misleading," Dr. Kee reports. "A 'reduced-fat' food might still be high in saturated fat or might contain higher amounts of sugar or sodium, which can confuse consumers trying to make healthier choices." Dr. Kee adds that the current hyperfocus on macronutrients—especially protein—can also lead people to reach for foods high in saturated fat. For instance, red meat is an "excellent" source of protein and saturated fat. Also? We're human. "Lifestyle factors like time constraints often lead individuals to opt for convenience foods, which are typically high in saturated fat, added sugars and sodium," he says.Related:
How To Eat Less Saturated Fat
It's hard to reduce your saturated fat intake. However, cardiologists emphasize that it's not impossible and is worth doing if you have high cholesterol or want to prevent it. "Reducing saturated fat intake is one of the most effective ways to protect heart health—and it doesn't have to mean giving up on flavor," Dr. Suri says.Here's how to eat less saturated fat:
1. Prioritize fruits, vegetables and whole grains
Deprivation is not on the menu when you're trying to manage cholesterol. Dr. Carstens recommends fiber-rich foods. Think apples, leafy greens and quinoa. "Loading up on these naturally low-fat and high-fiber foods helps displace higher-fat options in your diet and promotes fullness," he reveals.Next time you serve yourself a meal, take a look at your plate. Dr. Kee recommends loading half of it with vegetables.
2. Opt for leaner or plant-based protein
Protein is an essential macronutrient, but Dr. Carstens says that choosing leaner cuts or plant-based options can help you cut back on saturated fat intake. Think skinless chicken, fish and legumes. If your cravings call for red meat, opt for a leaner cut. Dr. Kee is a fan of Meatless Monday, though any day to go full-on vegetarian works."Aim for at least one meatless meal per week to explore new protein options," he recommends.
3. Replace saturated fats
Remember, "fat" isn't a dirty word, even when you're trying to reduce your cholesterol. The type of fat you regularly use to drizzle on salads or cook with can make a significant difference in your heart health. "Replace saturated fats with healthier options," Dr. Serwer advises. "Some excellent options include olive oil or avocado oil instead of butter or coconut oil."
4. Become a label detective
When perusing the grocery store, be sure to look at the back of the food bag or canister, which paints a clearer picture of whether it's heart-friendly. "Many packaged and processed foods contain hidden saturated fats, even ones labeled healthy," Dr. Suri warns.However, cardiologists emphasize that it's not impossible, and is worth doing if you have high cholesterol or want to prevent it. "A simple guideline is to choose foods with no more than 1 gram of saturated fat per 100 calories," Dr. Kee notes. "However, be mindful that 'reduced-fat' products might compensate with higher sugar or sodium content."
5. Limit eating out
Many chain menus post nutrition information, and it's worth taking the time to read. However, Dr. Serwer says opting for home-cooked meals more often than not is a best practice for your heart health (and wallet, if we're being honest).
"The best way to reduce saturated fats is to know what you are eating," he says. "Try your best to avoid eating at restaurants where ingredients are unknown."
Up Next:Sources:
Heart and Stroke Statistics. American Heart Association.
Dr. Patrick Kee, MD, Ph.D., a cardiologist with Vital Heart & Vein in Houston
Dr. Bradley Serwer, MD, an interventional cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company
Dietary saturated fat and cholesterol: cracking the myths around eggs and cardiovascular disease. Journal of Nutritional Science.
The Skinny on Fats. American Heart Association.
Dr. Bhavna Suri, MD, a cardiologist with Manhattan Cardiology in NYC and labfinder.com contributor
Saturated Fats. American Heart Association.
Dr. Jeffrey Carstens, MD, MBA, a cardiologist with UnityPoint Health
Cardiologists Are Begging People With High Cholesterol To Stop Doing This One Thing ASAP first appeared on Parade on Jul 21, 2025
This story was originally reported by Parade on Jul 21, 2025, where it first appeared.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'
Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Yahoo

time28 minutes ago

  • Yahoo

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company's recent earnings report results, Cramer said: 'Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we've long owned for the Charitable Trust… I'd say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook. wavebreakmedia/ Abbott (NYSE:ABT) is a healthcare company engaged in the research, development, manufacture, and marketing of a wide range of medical products. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

Yahoo

time28 minutes ago

  • Yahoo

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

Eli Lilly and Company (NYSE:LLY) is one of the . Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company (NYSE:LLY) is a research-driven pharmaceutical leader headquartered in Indiana. With a 150-year history, the company carries on the business of discovering, developing, manufacturing, and marketing innovative treatments across diseases like diabetes and in fields like oncology, immunology, and neuroscience. Some of the company's notable products, such as Humalog, Trulicity, Mounjaro, and Zepbound, are marketed in over 125 countries. The company is carrying on multiple studies and its latest updates include the Phase 2b clinical study titled 'A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa' and Phase 3 clinical study titled 'A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic Rhinosinusitis With Nasal Polyps on a Background Therapy With Intranasal Corticosteroids.' Along with these studies, the company has a pipeline with potential drugs capable of generating more than $1 billion in annual revenue. Amid these studies, the company has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion. With this acquisition, Eli Lilly and Company (NYSE:LLY) aims to strengthen its positions in gene editing for cardiovascular conditions. With a beta of 0.44 signaling the company's resistance to market conditions, Eli Lilly and Company (NYSE:LLY) has a high anticipated 5-year EPS growth of 41.87%, making the stock a strong contender in our list. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None.

Vektor Medical's vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care
Vektor Medical's vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care

Yahoo

time28 minutes ago

  • Yahoo

Vektor Medical's vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care

Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time SAN DIEGO, July 23, 2025--(BUSINESS WIRE)--Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. vMap, developed with AI and designed to localize both focal and fibrillation-type arrhythmias, delivers actionable insights in all four chambers of the heart in less than a minute. Clinical studies have shown that use of vMap is associated with a reduction in procedure time, which may reduce fluoroscopy time and improve safety. vMap integrates seamlessly into existing systems, making it an increasingly valuable solution for electrophysiologists seeking greater efficiency and performance without compromise. vMap is now in use at over 20 hospitals throughout the United States. "vMap has become an integral part of how I care for patients," said Dr. Anish Amin, Section Chief, Electrophysiology, OhioHealth Heart and Vascular. "It's efficient, non-invasive, and delivers insights that enhance every stage of the ablation process from planning through execution. With vMap, I can pinpoint arrhythmia sources faster with greater confidence, treat more accurately, and potentially reduce repeat interventions for patients. I'm looking forward to enrolling patients in the IMPRoVED-AF study, which will further validate the clinical impact of this technology and its potential to transform how we approach AF ablation." As adoption of pulsed field ablation (PFA) accelerates, the need for accurate, accessible data is greater than ever. vMap can enhance the impact of PFA by helping EPs identify optimal ablation targets before entering the lab and reiteratively during the procedure. With vMap's rapid, non-invasive ECG-based driver localization, physicians have more information to better target areas of interest, supporting more efficient procedures and unlocking the full potential of PFA. "This milestone represents meaningful momentum," said Robert Krummen, CEO of Vektor Medical. "With every procedure, physicians are leveraging vMap's rapid, non-invasive insights to make informed decisions and streamline care. We're seeing growing demand quarter over quarter as both physicians and hospitals look for ways to enhance efficiency and elevate patient care." The vMap system is FDA-cleared and commercially available in the United States. As clinical use continues to expand, Vektor Medical remains focused on advancing the future of arrhythmia care through clinical innovation, strategic partnerships, and physician impact. To learn more about Vektor Medical, vMap technology, or to request a clinical or strategic briefing, visit and connect with us on LinkedIn and X. About Vektor Medical Headquartered in San Diego, Vektor Medical is redefining how arrhythmias are understood and treated. The company developed vMap®, the only FDA-cleared, non-invasive technology that uses standard 12-lead ECG data to localize arrhythmia source locations across all four chambers of the heart. By helping physicians identify arrhythmia drivers more quickly and with greater accuracy, Vektor is improving outcomes, enhancing efficiencies, and accelerating access to effective treatment strategies. To learn more, visit View source version on Contacts Media Contact Stacey HolifieldLevitate(617) 233-3873vektor@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store